MySize, Inc. (Nasdaq: MYSZ) announced its financial results for the third quarter and nine months ended September 30, 2026, reporting a decrease in quarterly revenue and significant operating losses, while highlighting growth in specific segments and a restructuring initiative.

For the third quarter of 2026, total revenue was $1.86 million, a decrease of approximately 28% compared to the prior-year period of $2.57 million. The decline was primarily attributed to lower Amazon sales resulting from reduced inventory availability. Despite the overall revenue drop, the company reported growth in its SaaS and resale segments. SaaS Solutions revenue increased 25% year-over-year to $240,000 with a gross margin of approximately 82%, while resale platform revenue grew 19% to $413,000.

On the cost side, MySize implemented an operational restructuring in September. The company reduced the workforce at its Naiz Fit subsidiary by approximately 50%, which it estimates will result in annualized gross cost savings of approximately $793,000. The restructuring is intended to align operating expenses with current business conditions and improve resource allocation.

For the first nine months of 2026, the company generated revenue of $7.32 million, representing an increase of approximately 21% compared to $6.06 million in the same period in 2025. However, the company reported a net loss of $5.03 million for the nine-month period, compared to a net loss of $2.85 million in the prior year.

MySize also disclosed its balance sheet and liquidity position as of September 30, 2026. The company held approximately $2.28 million in cash and cash equivalents and $130,000 in restricted cash, totaling approximately $2.41 million. Management stated that existing cash will be sufficient to fund operations for less than 12 months, and substantial doubt exists regarding the company's ability to continue as a going concern.

In a separate strategic initiative, MySize announced it is evaluating potential acquisitions in the defense technology sector. The company stated it intends to evaluate opportunities based on technological differentiation, commercial prospects, and strategic fit. Any potential transaction would be subject to due diligence, financing availability, and regulatory approvals.